Clinical and Hemodynamic Outcomes of Rapid-Deployment Aortic Bioprostheses.
D'Onofrio A, Tessari C, Cibin G, Lorenzoni G, Martinelli GL, Solinas M, Gerosa G; INTU-ITA group; Gregori D, Alamanni F, Polvani G, Massetti M, Eusanio MD, Merlo M, Vendramin I, Mangino D, Mignosa C, Russo C, Rinaldi M, De Paulis R, Pacini D, Luzi G, Antona C, Salvador L, Musumeci F, Maselli D, Colli A, Portoghese M, Alfieri O, De Filippo CM.
D'Onofrio A, et al.
Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):453-461. doi: 10.1053/j.semtcvs.2021.04.006. Epub 2021 May 9.
Semin Thorac Cardiovasc Surg. 2022.
PMID: 33979664
At discharge transaortic peak and mean gradients were: 18 mm Hg (IQR: 14-23 mm Hg) and 10 mmHg (IQR: 8-13 mm Hg), respectively. Indexed effective orifice area was 1.10 cm(2)/m(2) (IQR: 0.91-1.31 cm(2)/m(2)) and the incidence of severe patient-prosthesis mismatch was 0.6%. …
At discharge transaortic peak and mean gradients were: 18 mm Hg (IQR: 14-23 mm Hg) and 10 mmHg (IQR: 8-13 mm Hg), respectively. Indexed effe …